VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Jincheng Pharma: Investee Company ApolloBio's VGX-3100 Phase III Trial Meets Primary Efficacy Endpoint
Jincheng Pharma: Investee Company ApolloBio's VGX-3100 Phase III Trial Meets Primary Efficacy Endpoint
May 20, 2026 16:58 CST Updated 17:24
Share: